Our promise to you:
Guaranteed product quality, expert customer support.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, previously provisionally named 2019 novel coronavirus or 2019-nCoV) is the strain of coronavirus that causes coronavirus disease 2019 (COVID-19), a respiratory illness. SARS-CoV-2 is a positive-sense, single-stranded RNA virus belonging to the genus Betacoronavirus. It is spread by human-to-human transmission via droplets or direct contact, and infection has been estimated to have mean incubation period of 6.4 days. Studies have shown that the disease caused by SARS-CoV-2, recently named as COVID-19 (coronavirus disease 2019) by World Health Organization (WHO), could induce symptoms including fever, dry cough, dyspnea, fatigue, and lymphopenia in infected patients. In more severe cases, infections causing viral pneumonia may lead to severe acute respiratory syndrome (SARS) and even death. Since the first report of COVID-19 in December 2019 in Wuhan, China, it has rapidly spread across China and many other countries. So far, SARS-CoV-2 has affected more than 28 countries/regions and has become a major global health concern. However, knowledge about this novel virus remains limited. It is still unclear about the origins and possible intermediate animal vectors of SARS-CoV-2, as well as the mechanism of spreading between persons. And the antiviral therapy and vaccination are currently under evaluation and development.
Creative Biogene, as a leading biotechnology company, is able to offer a comprehensive selection of SARS-CoV-2 ORF clones to assist the researchers to accelerate your pursuit to better understand SARS-CoV-2 and to ultimately conquer it.